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ABSTRACT
Retrotransposed sequences arise from messenger
RNAs (mRNAs) that have been reinserted into
genomic DNA by reverse transcription. Usually,
these sequences are embedded in dormant
regions, collect missense mutations over time and
constitute processed, nonfunctional pseudogenes.
There are thousands of processed pseudogenes in
the mouse and human genome. Here, we report
evidence for two paralog genes (termed Arxes1
and Arxes2), which arose by retrotransposition of
the signal peptidase Spcs3 followed by a segmental
duplication event. They gained a functional
promoter that we show to be transactivated by
adipogenic transcription factors. We further show
that the Arxes mRNAs are highly expressed in
adipose tissue and strongly upregulated during
adipogenesis in different cell models. Additionally,
their expression is elevated by an anti-diabetic
agent in vitro and in vivo. Importantly, we provide
evidence that the Arxes genes are translated and
that the proteins are located in the endoplasmic
reticulum. Although the sequence similarity and
subcellular location are reminiscent of their
parental gene, our data suggest that the Arxes
have developed a different function, since their
expression is required for adipogenesis, whereas
Spcs3 is dispensable. In summary, we report
retrotransposed-duplicated genes that evolved
from a parental gene to function in a tissue and
adipogenesis-specific context.
INTRODUCTION
As obesity and its associated diseases spread worldwide,
and can now be termed pandemic, fat cell and fat tissue
biology have increasingly gained researchers’ attention.
This is based on research over the last 20 years, redeﬁning
adipose tissue from a passive fat storage to a highly
reactive, interactive and endocrine organ. Growth of
adipose tissue is the result of the development of new fat
cells from precursor cells (hyperplasia) and/or the increase
of existing fat cells in volume (hypertrophy). The process
of fat cell development, known as adipogenesis, leads to
the accumulation of lipids and an increase in the number
of fat cells.
Cumulative evidence describes adipogenesis as a process
coordinated by a cascade of transcription factors acting
together to turn progenitor cells into lipid-storing, insulin-
responsive adipocytes (1–3). Much research focused on
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proliferator-activated receptor gamma (PPARg) and CC
AAT/enhancer-binding protein alpha (C/EBPa). The
nuclear receptor PPARg was shown by several loss- and
gain-of-function studies to be necessary and sufﬁcient for
in vitro adipogenesis (1) as well as for development of
adipose tissue in mice (4). Importantly, PPARg is the
target of thiazolidinediones (TZDs), a class of antidiabetic
drugs. The C/EBP protein family is comprised of six basic
leucine zipper transcription factors (5). While C/EBPb and
C/EBPd play essential roles in early adipogenesis, C/EBPa
is upregulated together with PPARg at a later point to
synergistically act on target genes during maturation
of adipocytes (6). More recent evidence shows that
C/EBPb, along with C/EBPa, is also expressed during
late adipogenesis and essential for it to occur (6). In
addition to PPARg and the C/EBPs, a number of other
transcription factors are reported to be involved in the
adipogenic network (1–3). Recently, factors with enzym-
atic activity have also been described as essential modula-
tors of adipogenesis (7–9). However, the list of adipogenic
regulators and the knowledge of the exact ‘wiring’ of its
components remain incomplete.
Here, we aimed to identify novel C/EBP target genes
during adipogenesis. We used a combined in silico and
experimental approach and employed a unique mouse
model of dominant-negative C/EBP expression. Within
the set of validated candidates, there was an uncharac-
terized Riken transcript. Bioinformatic analyses identiﬁed
a paralog sequence 40kb upstream and suggested that
both sequences, which we termed Arxes (Adipocyte-
related X-chromosome expressed sequence) arose by
retrotransposition from the signal peptidase Spcs3
followed by a segmental duplication. Functional
analyses showed completely different expression, regula-
tion and function of the Arxes compared to their parental
gene. We could show that the messenger RNA (mRNA) of
Arxes1 and Arxes2 is upregulated during adipogenesis in
different model systems by C/EBPa and PPARg/RXRa
through proximal promoter sites and possibly a distant
enhancer region. Furthermore, we provide evidence for
the existence of an endoplasmatic reticulum (ER)-
located protein translated from these mRNAs. Knocking
down Arxes1 and Arxes2 abolished differentiation of
3T3-L1 preadipocytes, while knockdown of Spcs3 had
no effect on adipogenesis. Finally, silencing of Arxes ex-
pression in mesenchymal stem cells also attenuated
adipogenesis while augmenting differentiation to osteo-
blasts. This suggests an important role of the Arxes in
cell commitment and in a metabolic context that is
distinct from that of their parental gene Spcs3.
MATERIAL AND METHODS
Cell culture and gene silencing
Mouse embryonic ﬁbroblast (MEF) cultures were estab-
lished from wild-type mice, and from transgenic mice ex-
pressing a protein that inhibits the DNA binding, and
thereby the transactivation potential, of the C/EBP
family of transcription factors (10). Transgenic mice
(subsequently termed A-C/EBP) were kindly provided by
Charles Vinson. These MEFs were harvested and cultured
as described elsewhere (11). Brieﬂy, pregnant mice were
sacriﬁced by cervical dislocation at Day 12.5 to 14.5 post
coitum and embryos were carefully dissected out and
separated from yolk sacs. The heads were used
for genotyping to determine transgenic cultures. In
phosphate-buffered saline (PBS), extremities and visceral
organs were separated from the torso, which was then
minced using a scalpel and homogenized by pipetting
several times. Three incubation steps with 0.25%
trypsin-EDTA (Invitrogen/Gibco) were performed (each
10min, 37 C) with pipetting in between. After adding
culture medium (aMEM, 10% FBS, 2mM L-glutamine,
100U/ml penicillin, 100mg/ml streptomycin; all from
Invitrogen/Gibco) cells were forced through a 20-gauge
needle using a syringe. Finally, cells were spun down
(3min, 200g), supernatant was removed and the cells
were resuspended in 20ml culture media, plated in a
75cm
2 culture ﬂask and cultured at 37 C and 5% CO2.
Medium was refreshed every third day and cells were
subcultivated (at a 3:1 rate) before they reached conﬂu-
ence. At passage one, cells (2 million per ml per tube) were
frozen in liquid nitrogen in medium with a supplementa-
tion of 10% DMSO (Sigma). Differentiation experiments
were performed at passage three. A standard DMI
mix [1mM dexamethasone, 500mM 3-isobutyl-1-
methylxanthine (IBMX) and 5mg/ml Insulin; all from
Sigma] was supplemented to the medium, along with
1mM rosiglitazone (Alexis), to initiate differentiation of
2 days post-conﬂuent cells. The addition of 1mM
rosiglitazone during the whole differentiation process
enhanced adipogenesis in wild-type MEFs, while not
changing the differentiation potential of A-C/EBP
MEFs. Medium was changed every other day, leaving
dexamethasone and IBMX out and reducing insulin con-
centration to 1mg/ml from Day 2 onward.
3T3-L1 cells were propagated and maintained in
Dulbecco’s modiﬁed Eagle’s medium (DMEM,
Invitrogen/Gibco) supplemented with 10% FBS, 2mM
L-glutamine, 100U/ml penicillin, 100mg/ml streptomycin
(all from Invitrogen/Gibco). Two days post-conﬂuent cells
were induced to undergo adipogenesis by addition of a
DMI cocktail and 1mM rosiglitazone when indicated.
From Day three on the hormonal cocktail contained
only 1mg/ml insulin. OP9 cells were differentiated with a
DMI protocol described in ref .12.
C3H10T1/2 cells were obtained from ATCC and main-
tained in DMEM supplemented as described above for
3T3-L1 cells. For adipogenic differentiation postconﬂuent
cells were treated with 100ng/ml BMP-2 (Sigma) for 3
days followed by incubation in DMI cocktail as described
above. For osteoblastogenic differentiation 100ng/ml
BMP-2, 10nM dexamethasone, 10mM b-glycerophosphat
and 50mg/ml L-ascorbic acid phosphate (all Sigma) were
added to medium of postconﬂuent cells. Medium was
changed every other day until harvesting on Day 10.
Lentiviral shRNA particles and a nontargeting control
construct were obtained from Sigma (SHVRS-
NM_029541 and SHC002V, respectively). The most ef-
fective silencing construct that is speciﬁcally directed
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the Spcs3 coding sequence Figure S5B) was used for
further experiments (NCBI probe ID: Pr008727591.1).
Infections of 3T3-L1 or C3H10T1/2 cells were followed
by puromycin (3mg/ml) selection. Lentiviral silencing par-
ticles targeting Spcs3 were obtained from Santa Cruz
Biotechnologies (TCR-5). Infections of 3T3-L1 cells were
performed according to manufacturer’s recommendations.
To stain for cytoplasmic triglycerides cells were ﬁxed with
4% paraformaldehyde for 1h and incubated for 30min
with the lipophilic dye oil red O (ICN). ALP activity
was measured as previously described (13). Brieﬂy, cells
were rinsed and harvested in homogenization buffer
(20mM Tris, 1mM EDTA, 1mM b-mercaptoethanol),
sonicated and mixed with p-nitrophenyl phosphate
(pNPP, Sigma). Reaction kinetics was measured with a
spectrophotometer at 405nm for 3min. Measurement
was normalized to protein contents determined with
BCA assay (Pierce).
Microarray analysis
For expression analyses of MEFs an in-house cDNA
platform (14) was used. Total RNA from four different
preparations from wild-type (WT) and from A-C/EBP
transgenic MEFs were harvested at speciﬁed time points
using Trizol reagent (Invitrogen) according to the
manufacturer’s protocol. Total RNA from each two prep-
arations were pooled leaving two biological replicates for
each WT and A-C/EBP MEFs. RNA samples were
reverse-transcribed and indirectly labeled as described pre-
viously (14). Eighty percent conﬂuent cells served as ref-
erence sample against which every time point sample was
hybridized in a dye-swap conﬁguration. Hybridization
was performed in a 42 C water bath for >16h. Slides
were scanned using an Axon scanner. After normalization,
the data were stored in the MARS database (15) and
exported to ArrayExpress (ID: E-MARS-11). Self-
organizing map (SOM) clustering was performed using
Genesis 1.6.0 (16). Differentially expressed genes in
Figure 1A are deﬁned as more than 2-fold deregulated
in at least one time point in transgenic or wild-type
MEFs compared to preconﬂuent MEFs. Genes showing
a differential proﬁle (positively regulated in late time
points of WT MEFs, while showing a ﬂat proﬁle in late
transgenic time points) were selected as follows:
Transcripts showing a difference between WT and trans-
genic log2-ratios of equal to or more than 0.5 in one or
both of the late time points (d3 and d8), while being dif-
ferentially expressed in the wild-type time point ( 1), were
included in this differential proﬁle. Potential C/EBP target
genes were subjected to Gene Ontology mapping using
ClueGO (17).
Bioinformatic analyses
Experimentally derived binding sites for the C/EBP family
of transcription factors were assembled in a position
weight matrix (PWM) from literature (Table S1).
Further, matrices were collected from the public
database TRANSFAC (18) to be included in the
downstream search (M00109, M00117, M00116,
M00159, M00190 and M00201).
Promoter sequences from the mouse genome (version:
mm7, Aug. 2005, NCBI Build 35) were obtained directly
from the UCSC genome browser (http://genome.ucsc.edu)
(19). Chromosomal coordinates of RefSeq genes (20) were
used to extract  5500bp to+2500bp relative to transcrip-
tion start sites (TSSs). These extracted regions were scored
against the different PWMs by using a MatInspector-
based algorithm (21) implemented in Perl. An optimized
matrix threshold was calculated for each PWM, which
permits a maximum of one hit (in average) in 10000-bp
segments of conjoined (repeat-masked) coding sequences
from all RefSeq transcripts. These optimized matrix
thresholds balance the differences in match frequencies
between short (unspeciﬁc) and long (more speciﬁc)
PWMs, based on the assumption, that hits in non-
regulatory (protein coding) sequences are occurring
merely by chance (22).
For detection of retrotransposition and duplication
events Arxes coding sequences from mouse (mm9) were
aligned against the genome versions of 29 organisms
[including mouse (mm9), rat (rn4), rabbit (oryCun2),
human (hg19) and chimp (panTro2)] using BLAT. Only
alignments with score >30 were considered. Spcs3 and
Arxes genomic sequences including 1000 bases up- and
downstream for mouse, rat, and rabbit (mm9, rn4 and
oryCun2) were retrieved from UCSC genome browser.
Blast2sequences with discontinuous MegaBLAST were
applied to get most extreme 30 and 50 genomic positions
of the alignment of Spcs3 against Arxes sequences.
Upstream sequences of the most extreme 50 genomic
position (–100/+10) [corresponding to 50 target site dupli-
cation (TSD) search space] and downstream of the most
extreme 30 genomic position (–10/+100) (=30TSD search
space) were extracted. To ﬁnd potential TSDs best local
alignments and relative scores (100*score/maximum
possible score) for subsequences of the 50TSD search
space (sliding window from 7 to 25nt) against the
30TSD search sequence were determined using EMBOSS
Matcher based on the lalign algorithm. PolyA sequences
between most extreme 30 genomic position of the align-
ments and the potential 30TSD were detected [starting
with at least 2 A in a row, stop on the occurrence of
two consecutive none-A (C,G,T,N), except if in a
look-ahead-window of 10nt >70% of As are present,
and with at least 7 As in total]. Distances and scores
were calculated as described elsewhere (23). Analyses
were performed using Perl 5.10.1.
In vivo experiments
Male C57/Bl6 mice were kept on a 12-h light/dark cycle
and housed according to institutional guidelines and
approved by the Austrian Bundesministerium fu ¨ r
Wissenschaft und Forschung. Four- to ﬁve-month-old
mice were fasted overnight and refed for  2h prior to
sacriﬁcing to synchronize their nutritional states. Mice
were fed with regular chow diet. For the rosiglitazone
study, mice were put on either chow diet or chow diet
with rosiglitazone (0.01% w/w) immediately after
3226 Nucleic Acids Research, 2011,Vol.39, No. 8weaning and kept on this diet for 7 weeks. Before harvest-
ing the epididymal fat pads, mice were fasted for 4h.
Statistics were calculated using a Student’s t-test.
P<0.05 was considered as signiﬁcant.
Western blot analysis
Transfected COS-7 and 3T3-L1 cells (at several differen-
tiation time points) were harvested for protein analysis by
scraping in lysis buffer (50mM Tris–HCl pH 6.8, 10%
glycerol, 2.5% SDS, 1  protease inhibitor cocktail,
1mM PMSF) after two washes with ice-cold TBS.
The suspension was incubated on 90 C for 10min.
Benzonase (Merck) was added followed by incubation at
room temperature for 1h. Protein concentration was
determined with the BCA protein assay kit from Pierce
according to the manufacturer’s instructions. Each lane
of a 10% Bis-Tris Gel (NuPAGE, Invitrogen) was
loaded with 40mg of sample. After electophoresis, gels
were blotted to Nitrocellulose-membranes (Invitrogen).
Blots were blocked and incubated with the following
antibodies: anti-Arxes (1:300 dilution), anti-b-actin
(1:25000; Sigma). For chemiluminescent detection horse-
radish peroxidase-conjugated secondary antibodies were
used (anti-rabbit for Arxes and anti-mouse for His
and b-actin, both 1:3000, Pierce) and ECL component
(Pierce) served as a substrate. Developed ﬁlms were
scanned with HP Scanjet at 600dpi.
Quantitative real-time reverse transcriptase polymerase
chain reaction
For quantitative real-time reverse transcriptase polymer-
ase chain reaction (qPCR) measurement samples
Figure 1. Combined computational and experimental approaches predict putative targets of C/EBP transcription factors in adipogenesis. (A) Venn
diagram of the intersection of the lists of differentially expressed genes containing predicted C/EBP binding sites (776) and C/EBP-dependent genes,
identiﬁed by expression analysis of wild-type and C/EBP dominant-negative MEFs during adipogenesis (280; see ‘Material and Methods’ section for
exact deﬁnition of gene groups). The intersection comprises 228 RefSeq-annotated genes, which constitute putative C/EBP targets. (B) A subset of
predicted C/EBP targets conﬁrmed by using ChIP-qPCR in MEFs at Day 3 of adipogenesis. Shown are fold-enrichments over input for primer pairs
aimed at predicted binding sites in promoter regions of potential C/EBP target genes. Fold-enrichments are normalized to signals from 18S rRNA
and related to genomic input DNA. An IgG reaction was performed to account for unspeciﬁc antibody binding (white bars). The TFIIB promoter
served as negative control. Values are mean values (±standard deviation) from three technical replicates. Shown are values from one representative
experiment out of three (Supplementary Figure S1C and S1D).
Nucleic Acids Research,2011, Vol.39, No. 8 3227totalRNA was isolated using Trizol reagent (Invitrogen)
according to the provider’s protocol, employing an extra
homogenization step for mouse tissues. Reverse transcrip-
tion was performed as described above. qPCR assays were
performed on 4.5ng cDNA in a 18ml SYBR green master
mix (Invitrogen) reaction on an ABI Prism 7000 sequence
detection system. Data were analyzed using a real-time
PCR management and analysis system [http://genome
.tugraz.at/qpcr; (24)]. Values were normalized to Uxt
and the algorithms from Zhao and Fernald (25) were
used to derive Ct values and PCR efﬁciencies. Primer se-
quences are to be found in Table S2.
Chromatin immunoprecipitation
MEFs or 3T3-L1 cells were grown in 15-cm dishes and
cross-linked at Day 3 of adipogenesis by incubating in 1%
formaldehyde for 20min while shaking at room tempera-
ture. Cross-linking was stopped by the addition of
0.125M glycine in PBS for 5min. Cells were harvested
in ice-cold PBS and subsequently incubated in 800ml cell
lysis buffer [10mM Tris pH8, 10mM NaCl, 0.2% NP-40,
1  protease inhibitor cocktail (PIC), 1mM PMSF] to
extract nuclei which were then lysed in 200ml ice-cold
nuclei lysis buffer (50mM Tris pH 8, 10mM EDTA,
0.8% SDS, 1  PIC, 1mM PMSF). Isolated chromatin/
DNA mixture was diluted with 200ml IP dilution buffer
(50mM Tris pH7.5, 150mM NaCl, 5mM EDTA, 0.5%
NP-40, 1% Triton X-100, 1  PIC, 1mM PMSF, 2mg/ml
BSA) and subjected to three 20-s bursts using an HD2070
sonicator (Bandlin) at 40% output. This yielded DNA
fragments of 200–600bp. This material was diluted 1:10
in IP dilution buffer before immunoprecipitation was
performed using anti-C/EBPa (Santa Cruz, sc-61),
anti-PPARg (Abcam, ab41928) and anti-IgG antibody
(Santa Cruz, sc-2027) and protein A/G plus-agarose
beads (Santa Cruz, sc-2003). Washing steps were per-
formed subsequently with IP dilution buffer, low salt
buffer (20mM Tris pH8, 50mM NaCl, 2mM EDTA,
0.1% SDS, 1% Triton X-100, 1  PIC, 1mM PMSF),
high salt buffer (20mM Tris pH8, 250mM NaCl, 2mM
EDTA, 0.1% SDS, 1% Triton X-100, 1  PIC, 1mM
PMSF), LiCl buffer (10mM Tris pH8, 0.25M LiCl,
1mM EDTA, 1% Na-deoxycholate, 1% NP-40, 1 
PIC, 1mM PMSF) and, ﬁnally, TE buffer. Before the
ﬁrst wash, the supernatant was set aside to serve as
input control. Immunoprecipitated chromatin and input
chromatin were reverse cross-linked, column puriﬁed and
ampliﬁed using a whole-genome ampliﬁcation kit (WGA2,
Sigma). Ampliﬁed DNA was subjected to qPCR analysis.
Measurements were normalized to an 18S rRNA
upstream region and related to input measurements to
obtain relative enrichment values. Primer sequences used
are given in Table S2.
Fluorescence microscopy
The Arxes CDS was cloned into a pCDNA4/HisMaxC
expression vector (Invitrogen) yielding an N-terminally
tagged Arxes protein using standard cloning procedures.
COS-7 cells and 3T3-L1 preadipocytes were seeded and
grown on coverslips (Corning #1.5). At 80% conﬂuence,
they were transfected with 1mg of an Arxes-HisMax con-
struct using 2ml MetafectenePro (Biontex). For negative
controls, an empty vector was transfected. The transfec-
tion was performed according to the manufacturer’s
manual. Forty-eight hours after transfection, the cells
were ﬁxed with 3.5% paraformaldehyde for 15min.
After ﬁxation, the cells were washed three times in PBS,
permeabilized for 10min in ice-cold 0.5% Triton-X 100
in PBS and again washed three times with PBS.
Immunodetection of His-tagged Arxes was performed by
incubating the cells over night at 4 C, with either a mono-
clonal antibody against the His-tag raised in mouse (GE
Healthcare Life Sciences, 27471001) or the customized
polyclonal antibody against the synthetic Arxes peptides
raised in rabbit (both 1:200 dilution in 4% BSA/0.1%
Tween-20/PBS). The cells were then washed three times
with PBS and incubated for 1h at room temperature
with an anti-mouse and an anti-rabbit antibody coupled
to AlexaFluor-488 and AlexaFluor-594 (both Invitrogen),
respectively. After washing three times with PBS, the
nuclei were counterstained with DAPI and the coverslips
were mounted on microscopy slides.
For endogenous Arxes detection 3T3-L1 preadipocytes
were grown on coverslips and ﬁxed for 15min with 2%
paraformaldehyde/0.4% glutaraldehyde/PBS. Conﬂuent
3T3-L1 adipocytes were detached at Day 7 of differenti-
ation with a trypsin (0.25%)/collagenase (0.5mg/ml) mix.
Cells were then seeded on coverslips in a lower density
to be accessible for antibodies before ﬁxation. After
quenching for 5min with 20mM glycine pH 8.5/PBS the
cells were washed three times with PBS, permeabilized
with 0.2% Triton-X 100/PBS and again washed three
times with PBS. In addition to the Arxes, the ER was
detected by a mouse anti-Calnexin antibody (Abcam,
ab31290). Both antibodies were diluted 1:200 in 4%
BSA/0.1% Tween-20/PBS and applied to the cells.
Incubation and subsequent steps were performed as
described above. All images were collected on a Zeiss
AxioImager Z1 epiﬂuorescence microscope using a 63 
1.4NA objective lens.
Luciferase reporter assays
Indicated proximal promoter elements were cloned in
pGl4.21 luciferase reporter vectors (Promega) using
standard procedures. The enhancer regions were cloned
in a pGl4.26 luciferase expression vector (Promega) con-
taining a minimal promoter. The Renilla reporter vector
pGl4.75 (Promega) was cotransfected in all experiments in
a ratio of 1:50 to luciferase reporter vectors, to control for
varying transfection efﬁciencies.
For the cotransfection in COS-7 cells C/EBPa CDS was
cloned in a pMSCV vector. Cloning of PPARg2 and
RXRa in pCMX expression vectors has been described
elsewhere (26). Cotransfection was done in 96-well plates
using MetafectenePro (Biontex) according to the pro-
vider’s protocol in ratio of 3:1 (ml MFP:mg DNA).
One-hundred nanograms of luciferase reporter vectors
were used. For PPARg, RXRa and C/EBPa, 25ng,
25ng and 50ng of DNA were employed, respectively.
After 48h cells were lysed and assayed according to
3228 Nucleic Acids Research, 2011,Vol.39, No. 8protocol provided with the Dual-Glo luciferase assay
system (Promega). Luminescence read-outs were
generated with a Berthold Orion II luminometer.
Relative Luciferase activity was calculated by referring
Renilla-normalized values to empty Luciferace vector
measurements (pGl4.21 or pGl4.26).
To efﬁciently transfect adipocytes with reporter vectors,
electroporation was carried out as follows. Differentiated
cells (d7–d9) were detached with a trypsin (0.25%)/
collagenase (0.5mg/ml) mix and 8 10
 6 cells/ml (in
10ml electroporation buffer provided by with the kit)
were mixed with 1mg reporter plasmid and pulsed with
1400V/30ms pulses using a Neon transfection system
(Invitrogen). For comparison, 3T3-L1 preadipocytes
were treated in the same way. Three electroporations
were reseeded in one well of a 24-well plate. After 48h,
cells were assayed and calculations performed as described
above.
RESULTS
Large-scale gene expression analysis during adipogenesis
in a wild type and a perturbation system reveals novel
C/EBP target genes
To identify novel target genes of C/EBPs during
adipogenesis, we employed mouse embryonic ﬁbroblasts
(MEFs) from wild-type and C/EBP dominant-negative
mice. As evidenced by oil red O staining and western
blotting, wild-type MEFs treated with adipogenic
cocktail differentiated into adipocytes, whereas
dominant-negative MEFs did not (Supplementary Figure
S1A, further validation can be found in Supplementary
Data). RNA was harvested at several time points during
the differentiation process up to Day 8 and subjected to
time-series microarray analysis (Supplementary Figure
S2A). Genes with a differential expression proﬁle
(upregulated in wild-type MEFs and not so in
dominant-negative MEFs) were then identiﬁed and
ﬁltered for RefSeq-annotated genes that contain a pre-
dicted C/EBP binding site close to their TSS (Figure 1A;
see ‘Material and Methods’ section for detailed proced-
ure). A list of the identiﬁed genes can be found in
Supplementary Table S1. These 228 RefSeq genes were
subjected to Gene Ontology (GO) analysis via ClueGo
(17) showing a highly signiﬁcant enrichment in metabolic-
ally important GO terms such as mitochondrion, lipid
metabolic processes, fatty acid metabolism, acetyl
CoA-related terms and generation of precursor
metabolites and energy (Supplementary Figure S3).
To further validate these predictions, we chose a
subset of four known C/EBP-bound genes and ﬁve yet
uncharacterized transcripts (annotated by the Riken con-
sortium as full length transcripts). We could show binding
of C/EBPa to the predicted binding sites in the upstream
sequence region of the selected transcripts using chroma-
tin immunoprecipitation followed by quantitative
real-time PCR (ChIP-qPCR) in MEFs differentiated for
3 days. As shown in Figure 1B, the enrichments of the
formerly uncharacterized genes are in general lower
compared to that of the bona ﬁde C/EBP target genes,
but show at least a 2-fold enrichment over input. Within
this set of uncharacterized transcripts, the strongest values
for enrichment were shown at regions upstream of
two Riken transcripts. The transcript 2310001RikA20
codes for a transmembrane protein and was recently
characterized in our lab as an important player in
adipogenesis (27). In this study, the transcript
6530401D17Rik was further investigated.
Genomic setup and sequence analyses of Adipocyte-related
X-chromosome expressed sequences (Arxes)
Close inspection of 6530401D17Rik identiﬁed it as an
intron-less gene, which is coded on the forward strand
of the X-chromosome of the mouse genome. Its coding
sequence (CDS) is identical to another Riken gene
(2900062L11Rik), located  40kb upstream (see Figure
5F for genomic overview). As these two genes have
more in common than just their CDSs (e.g. tissue expres-
sion pattern, regulation; see later) we will refer to them
as Arxes, for Adipocyte-related X-chromosome expressed
sequences (Arxes1 for 6530401D17Rik; Arxes2 for
2900062L11Rik).
The analysis of the predicted amino acid sequence of
both Arxes suggest that they share a common architecture
with Signal peptidase complex subunit 3 (Spcs3,
NP_083977.1, Supplementary Figure S4), a known signal
peptidase (28) catalyzing cotranslational cleavage of signal
peptides from nascent proteins in the ER. Each of these
three proteins contains a transmembrane segment
(residues 11–32) and a PFAM domain SPC22 hit
(residues 1–175). The Spcs3 locus can be found on
chromosome 8 and the gene consists of ﬁve exons. On
the nucleotide level, the Arxes CDSs are 79% identical
to the Spcs3 CDS and on the amino acid level the Arxes
and Spcs3 show 82% identity (see Table 1 for mutual
alignments). These strong homologies suggest that the
Arxes were integrated into their loci via retrotransposition
of the Spcs3 mRNA. To investigate the retrotranspositon
event in more detail we used a sliding window and
sequence alignment approach to detect target site duplica-
tions [TSDs, short direct repeats ﬂanking the sequences
inserted by retrotransposition (23,29)] in the 50 upstream
and 30 downstream regions of the sequences homologous
between the Arxes loci and the Spcs3 mRNA. Indeed, this
analysis yielded 7-nt TSDs directly 50 and 30 of the
Table 1. Multiple alignments of Arxes1, Arxes2 and Spcs3 promoters
and transcripts
Alignments Promoter 50UTR CDS 30UTR Amino acid
sequence
Spcs3 vs Arxes1 (%) 1 12 79 23 82
Spcs3 vs Arxes2 (%) 3 18 79 7 82
Arxes1 vs Arxes2 (%) 85 99 100 5 100
Multiple alignments were performed by running ClustalW2 on the EBI
server.
Numbers shown are percent identity at the nucleotide level (except the
last column, which shows the amino acid identity of predicted protein
sequences).
For the promoter alignment 1kb upstream of the transcription start
sites was considered.
Nucleic Acids Research,2011, Vol.39, No. 8 3229homologous region indicative of a retrotransposition
event (Figure 2 and Supplementary Data ﬁle 1).
Interestingly, the Arxes sequences were annotated as
pseudogenes in the NCBI Build 36 (mm8, NR_003641
and NR_003642). Close inspection of the genomic
features of the Arxes though revealed a host of indications
that are atypical for nonfunctional pseudogenes: (i) Gene
prediction algorithms (e.g. GeneScan) identiﬁed an open
reading frame with no premature stop codons and no
frameshift mutations, as usually found in pseudogenes;
(ii) polyadenylation consensus sequences (ATTAAA) can
be found in the 30UTRs of both Arxes; (iii) a weak Kozak
sequence (30) is situated upstream of the start codons; (iv)
no repeat regions can be found within the Arxes CDSs;
and (v) a scan of 5000bp of upstream genomic sequence
using PROMOTER2.0 (31) predicts promoter sites.
To clarify the evolutionary history of the Arxes, we
applied BLAT of the mouse Arxes CDS against the
genome versions of 29 organisms (Supplementary Data
ﬁle 2). This analysis showed that both Arxes exist also
on the X-chromosome of the rat genome, while on the
X-chromosome of the rabbit only one homologous
sequence could be found. However, in primates no
Arxes homolog seems to exist. The homology of the two
mouse Arxes regions extend  800bp upstream and 50bp
downstream of the CDSs of Arxes1 and Arxes2, suggest-
ing that one of the two paralogs arose by segmental du-
plication [deﬁned as regions with a sequence similarity
 90% and a length  1bp (32)].
Hence, based on our analyses, we propose a model
(Figure 2) of the Arxes as retrotransposed from the
Spcs3 mRNA. This retrotransposition took place after
the speciation of primates and glires (33) with an addition-
al segmental duplication after the speciation of rabbit and
mouse/rat. The resulting sequences appear to have con-
tained an intact open reading frame.
Arxes1 and Arxes2 mRNA expression is highly
upregulated during in vitro adipogenesis, in adipose
tissue and by an antidiabetic agent
To distinguish mRNA expression of the two Arxes and
the Spcs3, qPCR primers were designed in the highly
distinct 30 UTRs (Table 1, Table S2 and Figure 5F).
With these speciﬁc primers, expression levels were
measured in 3T3-L1 cells, OP9 cells and MEFs during
adipogenic differentiation (Figure 3A–C), showing that
the Arxes transcripts are strongly upregulated during
adipogenesis. Their parental gene Spcs3, on the other
hand, was slightly downregulated in these cell models, as
was also observed for Spcs3 during differentiation of
human cell culture models for adipogenesis (data not
shown). The mRNA expression levels in metabolically
relevant mouse tissues were then measured (Figure 3D).
Arxes expressions in epididymal white (WAT) and brown
(BAT) adipose tissue were up to 70-fold higher compared
to expression in heart, while Spcs3 mRNA was differen-
tially expressed to a much lower level in these tissues (inset
of Figure 3D).
In age-matched female mice, the expression pattern
among tissues was similar to their male counterparts
(data not shown), suggesting that there is no sex-speciﬁc
gene dosage effect. Addition of the PPARg-agonist
rosiglitazone to 3T3-L1 adipocytes (Figure 3E) or OP9
adipocytes (Supplementary Figure S6) increased the ex-
pression of Arxes mRNAs. Furthermore, feeding mice
with a rosiglitazone-containing diet for 7 weeks elevated
the Arxes1 and Arxes2 mRNA in epididymal fat pads
when compared to mice on a normal diet (Figure 3F),
Figure 2. Model of evolutionary history of Arxes (adipocyte-related X-chromosome expressed sequences) loci. Schematic of the ‘phylogeny’ of the
Arxes genes based on bioinformatic analyses. Only one Arxes-like gene can be found on the rabbit x-chromosome while mouse and rat contain two
paralog regions adjacent to each other on the x-chromosome. Arxes genes exhibit intact open reading frames. Target site duplication (TSD)
sequences are given for mouse. A paralog stretch longer than the retrotransposed sequence (Arxes CDS including  800bp upstream and 50bp
downstream) suggests a segmental duplication event.
3230 Nucleic Acids Research, 2011,Vol.39, No. 8Figure 3. mRNA expression patterns of Arxes1, Arxes2 and Spcs3 during in vitro adipogenesis, in mouse tissues and upon in vitro and in vivo
rosiglitazone treatment. (A–C) Shown are qPCR measurements during the course of adipogenesis in three different cell models. Cells were induced
with DMI cocktails 2 days post conﬂuence (d0) as speciﬁed in ‘Materials and Methods’ section. Values are expressed relative to d0 measurements.
Data are presented as mean±SEM from two independent MEF isolations or two and three experiments for OP9 and 3T3-L1 cells, respectively.
(D) Distribution of mRNA expression in metabolically relevant tissues in wild-type mice. Expression is shown relative to heart as fold-expression.
Inset represents a scale-up of the Spcs3 expression values. Data are presented as mean±SEM (n=3). Abbreviations: WAT, white adipose tissue
(epididymal); BAT, brown adipose tissue (interscapular); L, liver; SM, skeletal muscle; H. heart. (E) 3T3-L1 adipocytes were treated with 1mM
rosiglitazone at Day 7 of differentiation. RNA was harvested 24h after rosiglitazone treatment or medium change (DMEM) and measured with
qPCR using the indicated primers. Data are represented as mean±SEM from three independent experiments. Student’s t-test: **P<0.01. (F) Male
mice were kept on a rosiglitazone-containing chow diet (0.01% w/w) or on normal chow for 7 weeks post-weaning. Prior to harvesting epididymal fat
pads mice were fasted for  4h to synchronize nutritional states. Data are represented as mean±SEM (n=5–6). Student’s t-test: **P<0.01.
Nucleic Acids Research,2011, Vol.39, No. 8 3231whereas Spcs3 mRNA was downregulated by in vivo
rosiglitazone treatment. Together, these results demon-
strate that the Arxes mRNAs are highly upregulated
during adipogenesis of several in vitro models as well as
in adipose tissue (compared to other metabolic tissues)
and that their mRNA levels increase massively upon
rosiglitazone treatment, while their parental gene Spcs3
shows no upregulation in any of these conditions.
Protein evidence and subcellular localization of the Arxes
Processed pseudogenes are deﬁned as genomic sequences
retrotransposed from a parental mRNA, which no longer
translate into functional proteins (34). To determine if the
Arxes are nonfunctional, processed pseudogenes, we
tested whether the Arxes yield a protein or if they exert
their putative function as noncoding RNA as recently
reported for other pseudogenes in mouse oocytes (35).
Therefore, we established a polyclonal Arxes antibody
directed against peptides that confer speciﬁcity over
Spcs3 (Supplementary Figure S5A). To verify the speciﬁ-
city of this antibody we transiently expressed 6xHis-tagged
Arxes in COS and 3T3-L1 cells. A strong overlap of the
anti-His and the anti-Arxes staining could be shown with
immunoﬂuorescence microscopy in both cell types
overexpressing His-tagged Arxes (Figure 4A).
To rule out a cross-reactivity with Spcs3, western blot
analysis on 3T3-L1 cells during adipogenesis was per-
formed, which showed a steady increase of endogenous
protein levels during differentiation (Figure 4B). This
pattern correlates with the mRNA proﬁle of Arxes1 and
Arxes2, but not with that of Spcs3 (Figure 3A), thus
indicating that the antibody is speciﬁc for the Arxes
proteins. Further, knockdown of Arxes in 3T3-L1 cells,
as described below, was used to prove the speciﬁcity of the
antibody with western blotting (Figure 4C). Finally, we
performed immunoﬂuorescence microscopy to investigate
the localization of endogenous Arxes in 3T3-L1
preadipocytes and mature adipocytes and found that the
Arxes staining in both cases overlaps with the signal of the
ER marker Calnexin (Figure 4D). Thus, we provide
evidence that the Arxes transcripts are indeed translated
into protein, which accumulates during adipogenesis and
localizes to the ER in 3T3-L1 preadipocytes and
adipocytes.
The Arxes are synergistically regulated by PPARc and
C/EBPa
The fact that the Arxes mRNAs are increased by the
PPARg agonist rosiglitazone and our initial identiﬁcation
of Arxes1 as potential C/EBPa target gene suggest that the
Arxes might be regulated by both pivotal transcription
factors of adipogenesis. In agreement with this, in silico
analyses using the Genomatix software suite (36) identiﬁed
potential PPARg and C/EBP binding sites in both Arxes
promoters (Supplementary Figure S7). According to these
predictions, truncations of the Arxes proximal promoters,
including the 50UTR 139bp downstream of the TSS, were
cloned into Luciferase reporter vectors. Next, we
cotransfected the Luciferase reporter vectors with
PPARg/RXRa and C/EBPa expression plasmids or
empty vectors into COS cells. As depicted in Figure 5A,
we found a >60-fold increase in Luciferase activity in
promoter elements that contain the TSS (–182 to
+139bp) compared to downstream promoter elements
(+33 to +139bp) or to empty luciferase vectors. This
increase, however, seems to be independent of whether
PPARg/RXRa and C/EBPa transcription factors are
present and indicates a strong basal promoter activity
mediated by elements in the region between  182 and
+33bp around the Arxes TSSs. Note that the ﬁrst 689bp
upstream of the Arxes TSSs and their 50UTRs are highly
homologous (99% and 100%, respectively). However, a
PPARg/RXRa/C/EBPa-dependent increase in Luciferase
activity could only be found further upstream (Figure 5A).
For Arxes1, a signiﬁcant increase was observed starting
with promoter length of 869bp upstream of the TSS. For
Arxes2, around 4kb upstream had to be cloned to elicit a
signiﬁcant transcription factor dependency (Figure 5A).
In addition to the proximal promoters, we investigated
genomic sites around the Arxes that were identiﬁed to be
bound by C/EBPa and PPARg in a recently published
genome-wide location study by Lefterova et al. (6). In
the vicinity of the Arxes, three regions were identiﬁed by
this study to be bound by both transcription factors (see
genomic overview Figure 5F). One binding region
upstream of Arxes2 (2900062L11Rik in Figure 5F)
directly overlaps with the longest Arxes2 promoter
fragment in Figure 5A, supporting our ﬁnding of signiﬁ-
cant increase of luciferase activity in a PPARg/RXRa/C/
EBPa-dependent manner. The two other regions—one
about 20kb upstream and one  8kb downstream of the
Arxes1 gene—were cloned into Luciferase reporter vectors
containing a minimal promoter. Figure 5B shows a signiﬁ-
cant increase in reporter activity of the 8kb downstream
region after cotransfecting this reporter vector with
PPARg/RXRa and C/EBPa expression vectors into
COS cells.
Compared to preadipocytes, luciferase activity increased
nearly 7-fold when this construct was electroporated into
3T3-L1 adipocytes (which have high endogenous levels of
PPARg, RXRa, and C/EBPa; Figure 5C). However, the
region  20kb upstream of Arxes 1 did not show any sig-
niﬁcant difference in the tested experimental setups
(Supplementary Figure S8). To verify binding of PPARg
to the Arxes1 8kb downstream region (Arxes1_8kb_DS)
ChIP-qPCR was performed in 3T3-L1 cells at Day 3 of
differentiation when Arxes mRNA levels are highest.
Figure 5D shows an enrichment over input that is compar-
able with the positive control regions [known PPARg
binding site in the hormone-sensitive lipase promoter
(37)]. The TFIIB promoter served as negative control.
Also, the C/EBPa ChIP in MEFs was assayed with this
primer pair speciﬁc for the Arxes1_8kb_DS region and
showed a strong enrichment over input (Figure 5E).
Collectively, our data suggest that the proximal pro-
moters of Arxes1 and Arxes2 are functional and can be
induced by the adipogenic master regulators, PPARg and
C/EBPa. Furthermore, an enhancer region 8kb down-
stream of Arxes1 was shown to be strongly bound and
activated both by transcription factors and in an
adipogenic context.
3232 Nucleic Acids Research, 2011,Vol.39, No. 8Arxes-speciﬁc silencing abrogates adipogenesis and
enhances osteoblastogenesis
To investigate whether the Arxes are functional in
adipogenesis we applied a loss-of-function approach
using shRNA-based constructs that speciﬁcally and
stably silence Arxes in 3T3-L1 cells (see Figure 6A and
sequence in Supplementary Figure S5A). Intriguingly,
when cells were transduced with lenti-viruses containing
an Arxes-speciﬁc silencing construct (siArxes in Figure 6),
adipogenesis was completely abolished, while cells infected
with nontargeting control (ntc) shRNA differentiated
normally after DMI treatment (see upper panel of
Figure 6B for oil red O staining and Figure 6C for
adipogenic markers at Day 7 of adipogenesis). However,
if rosiglitazone is added to the differentiation cocktail the
differentiation defect in silenced cells can be partly
overcome (Figure 6B, lower panel of oil red O staining).
In stark contrast to the Arxes silencing, speciﬁc
Figure 4. Protein evidence and localization of Arxes in the ER. (A) Shown are 3T3-L1 and COS cells overexpressing Arxes with a 6xHis-tag.
Right-most panels show merge of all channels. Scale bars represent 10mm. (B) Protein was harvested at indicated time points during 3T3-L1
differentiation and subjected to western blotting using the anti-Arxes antibody. b-Actin served as loading control. Increase in protein level is in
concordance with Arxes mRNA measurements. (C) 3T3-L1 cells were transduced with silencing constructs (siArxes) or non-targeting control (ntc),
and induced to undergo adipogenesis for 7 days with standard DMI treatment. Western blot analysis is performed on protein lysates to prove
speciﬁcity of antibody. b-Actin served as loading control. (D) Endogenous Arxes protein location is shown in the red channel for preadipocytes and
mature adipocytes (d8). The merged image shows a high degree of overlap with the ER-marker Calnexin, as also shown by the channel intensity
proﬁle in the inset. Scale bars represent 10mm.
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Nucleic Acids Research,2011, Vol.39, No. 8 3235(Figure 6D) and stable silencing of Spcs3 in 3T3-L1 cells
did not impair adipogenesis or reduce adipogenic marker
genes, as illustrated in Figure 6E for Day 7 of adipogenesis.
These data suggest that an increase in transcript levels of
the Arxes is required for the expression of adipogenic key
regulators. Thus, the results of the silencing approach
provide evidence that Arxes1 and Arxes2, but not their
parental gene Spcs3, are required for adipogenesis, which
suggests different functions of these evolutionary relatives.
However, it should be noted that stable overexpression of
Arxes proteins in 3T3-L1 cells did not inﬂuence
adipogenesis, neither under normal adipogenic differenti-
ation conditions (Supplementary Figure S9) nor when
using suboptimal differentiation mixes (data not shown).
To evaluate whether Arxes are only necessary for the
differentiation of preadipocytes to adipocytes or if they
play a broader role in early developmental stages we
used Arxes-speciﬁc silencing in mouse C3H10T1/2 cells.
C3H10T1/2 is a pluripotent mesenchymal stem cell line
that can be differentiated in a variety of cell types,
including adipocytes and osteoblasts (13). Here, we
stably silenced Arxes expression in C3H10T1/2 cells
before we induced their differentiation into either
adipogenic or osteoblastogenic lineages. Corroborating
our ﬁndings in 3T3-L1 cells, Arxes-silenced C3H10T1/2
cells exhibit reduced adipogenesis when compared to ntc
control cells, as assessed by oil red O staining (Figure 7B)
and mRNA levels of adipogenic marker genes such as
PPARg2 (Figure 7A) and Fabp4 (data not shown).
Interestingly, silencing of Arxes increased osteo-
blastogenic potential of C3H10T1/2 cells. This is
evidenced by increased ALP mRNA expression (Figure
7C) and >4-fold elevated ALP activity (Figure 7D), a
hallmark of osteoblast differentiation (13). Hence, our
data suggest that Arxes play a role in lineage commitment
of mesenchymal stem cells, because osteoblastogenesis
is promoted while adipogenesis is repressed upon
knockdown of Arxes in C3H10T1/2 cells.
Figure 7. Silencing of the Arxes in C3H10T1/2 pluripotent stem cells reduces adipogenesis and enhances osteoblastogenesis. C3H10T1/2 cells were
transduced with silencing constructs (siArxes) or nontargeting control (ntc), and induced to undergo adipogenesis or osteoblastogenesis for 10 days as
described in ‘Material and Methods’. Results are representative of two independent replicates each performed in triplicates (mean±SEM).
(A) Expression of PPARg was measured with qPCR before differentiation and on Day 10 of adipogenesis in Arxes-silenced and control cells.
Arxes CDS primer pair recognizes mRNA levels of both Arxes as it is aimed at the coding sequence. (B) Oil red O staining shows reduced lipid
droplet formation in Arxes-silenced cells at Day 10 of adipogenesis, which is in concordance to the results in 3T3-L1 cells. (C) qPCR measurements
show that mRNA levels of ALP are increased in Arxes-silenced cells. (D) At Day 10 of osteoblastogenesis cells were homogenized and mixed with
pNPP solution and kinetics were recorded for 3min using a spectrophotometer at 405nm. Measurements were normalized to protein contents.
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In this study, we employed a combined computational/
experimental approach and identiﬁed a set of previously
unknown C/EBP target genes. We then further
characterized one of the validated targets (Arxes1) and
its paralog Arxes 2, both of which appeared to be
retrotransposed genes of the signal peptidase Spcs3.
Functional studies showed divergent expression, regula-
tion, and function of the Arxes compared to their
parental gene Spcs3. Moreover, several lines of evidence
suggest that Arxes are novel key proteins in adipogenesis:
(i) mRNAs of Arxes1 and Arxes2 were upregulated in cell
models of adipogenesis and highly expressed in adipose
tissue of mice, (ii) Arxes are synergistically regulated by
C/EBPa and PPARg, (iii) Arxes are translated and their
gene products are localized in the endoplasmatic reticulum
and (iv) silencing of Arxes1 and Arxes 2 blocked
adipogenesis and enhanced osteoblastogenesis.
A major ﬁnding for fat cell biology is that upon
silencing of the Arxes in 3T3-L1 cells differentiation is
impaired, rendering the Arxes as essential players in the
process of mouse fat cell differentiation. Moreover, this
differentiation defect could be partly rescued by the
addition of the PPARg agonist rosiglitazone to the differ-
entiation mix of the silenced cells. This may suggest that
the Arxes function in pathways producing endogenous
PPARg ligands that can be bypassed by addition of syn-
thetic ligands. With this, the Arxes join a line of recently
described molecules that have been shown to be necessary
for adipogenesis and that were proposed to be involved in
PPARg ligand production pathways, such as RetSat (7)
and XOR (8).
Along this line of argumentation, the close relationship
of the Arxes and Spcs3 raises the question of whether the
Arxes function as signal peptidases and thereby in the se-
cretory pathway. The subcelluar location of the Arxes
proteins in the ER (Figure 4) supports this hypothesis.
Spcs3 was shown to be a member of the ER signal pep-
tidase complex comprised of ﬁve proteins in mammalian
systems (38,39). Spc3p, the yeast homolog of mammalian
Spcs3, has been shown to be essential for protein secretion
in yeast, where upon silencing of Spc3p, precursor
proteins accumulate in the ER, which is in turn incompat-
ible with survival (40). However, secretion via the classical
(adiponectin) and the nonclassical (visfatin) secretory
pathway (41) was not changed 48h after silencing of the
Arxes in mature adipocytes (unpublished ELISA data).
Also, silencing of Spcs3 did not impair adipogenic differ-
entiation in 3T3-L1 cells. These data suggest that,
although the Spcs3 protein and the Arxes proteins have
a similar sequence architecture, the same hydrophobic
pattern and the same predicted three-dimensional (3D)
structure in the globular domain (amino acids 40–175),
their function in adipogenesis is different. This difference
is possibly due to many residues with polar side chains
at homologous positions that are quite divergent in
their physico-chemical properties (see alignment
Supplementary Figure S4B). However, further studies
are necessary to elucidate the pathway(s) in which the
Arxes inﬂuence adipogenesis.
Another major ﬁnding is the identical transcriptional
regulation of the Arxes despite their separation by a
40-kb genomic DNA stretch. The regulatory upstream
regions of the Arxes are similar. Both Arxes contain a
promoter around the TSS (–182/+33 relative to TSS,
Figure 5A). Further upstream we could show PPARg/C/
EBPa-dependent induction of a reporter gene for both,
the Arxes1 and Arxes2 promoter. Interestingly, there is
an enhancer region situated 8kb downstream of the 30
end of Arxes1 to which C/EBPa and PPARg bind. This
region is capable of transactivating a reporter gene (Figure
5B and C). The mRNAs of the two Arxes genes were
coregulated in all experimental circumstances shown.
The strong homology of the ﬁrst  800bp of their pro-
moters and the fact that both of the Arxes promoters
are transactivated by PPARg and C/EBPa may explain
this coregulation. However, the contribution of the
region 8kb downstream of Arxes1 to the regulation of
both Arxes gene remains elusive. Using the chromatin
conformation capture (3C) method, the functionality
and direct action of such long-range chromatin inter-
actions were recently demonstrated for PPARg
-mediated activation of the Ucp2 and Ucp3 genes in
3T3-L1 adipocytes (42) and—on a genome-wide level—
for human estrogen-receptor-a (43). Additional experi-
ments using this 3C method could investigate a direct
interaction by means of looping between this 8kb down-
stream site and the Arxes promoters.
Finally, an intriguing result of this study is the speciﬁc
genomic conﬁguration of the Arxes. Arxes1 and Arxes2
are intronless genes and located adjacent to each other on
the mouse X-chromosome. They show high sequence simi-
larity in the regions immediately upstream of their TSSs
and possess identical CDSs. The Arxes CDSs are highly
homologous to the Spcs3 mRNA, expressed from a
six-exon gene on the reverse strand on mouse chromosome
8. Further, our analyses identiﬁed a region syntenic to the
mouse Arxes1–Arxes2 locus on the rat X-chromosome
and a single Arxes-like sequence on the X-chromosome
of the rabbit genome (Supplementary Data ﬁle 2), while
there were no such homologous sequences in primate
genomes. Based on this genomic setup, we propose that
one of the Arxes genes was retrotransposed from Spcs3
mRNA after the speciation of primates and glires,
followed by a segmental duplication event (32) after diver-
gence between rabbit and mouse/rat (Figure 2). A similar
‘phylogeny’ was recently reported in a study on human
GAPDH pseudogenes (44). The segmental duplication
could account for the high sequence similarity in the
 800bp upstream of the mouse Arxes TSSs. This
upstream promoter region was shown to be functional
and is highly conserved in rat, but not in the rabbit
Arxes locus. How the Arxes acquired a functional
promoter after the retrotransposition remains elusive.
Deeper investigation of the retrotransposition event
identiﬁed target site duplications (23,29) close to the 50
and 30 ends of the mouse and rat Arxes regions that are
homologous to Spcs3 mRNA (Figure 2). If these TSDs
indeed ﬂank the retrotransposed sequences, this would
present an explanation for the highly divergent 30UTRs
of Arxes1, Arxes2 and Spcs3 (Table 1). However, an
Nucleic Acids Research,2011, Vol.39, No. 8 3237L1-mediated retrotransposition event usually introduces a
polyA stretch directly 50 of the 30 TSD (45) by inserting the
entire mRNA of the parent gene. Such a polyA stretch
cannot be found at the Arxes loci. We reason that
the absence of a polyA stretch can be either due to
sequence degeneration or because the Arxes arose by an
L1-independent retrotransposition event.
Due to the high homology of Arxes CDSs and the Spcs3
mRNA sequence the Arxes loci were annotated as pseudo-
genes in the build 36 of the NCBI GenBank database.
However, we show here that the Arxes are transcribed,
regulated in adipogenic conditions and that they code
for ER-located proteins, which are necessary for the
process of in vitro fat development. Further, our experi-
ments in mesenchymal stem cells suggest a role in lineage
commitment. Hence, the Arxes defy the very deﬁnition of
a (processed) pseudogene (34). Keeping in mind that there
are about 20000 predicted pseudogenes in each the mouse
and the human genome (34), the results of our study
provoke a reconsideration and reevaluation of these
alleged evolutionary relics.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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